Longitudinal trends in antimicrobial susceptibilities across long-term-care facilities: emergence of fluoroquinolone resistance. - Wikidata - awgldk - TriplyDB

Longitudinal trends in antimicrobial susceptibilities across long-term-care facilities: emergence of fluoroquinolone resistance.

Longitudinal trends in antimicrobial susceptibilities across long-term-care facilities: emergence of fluoroquinolone resistance.

http://www.wikidata.org/entity/Q40448254

about

Antimicrobial susceptibility of bacteria isolated from urine samples obtained from nursing home residents.Antimicrobial stewardship programs in health care systems.Challenges and Strategies for Prevention of Multidrug-Resistant Organism Transmission in Nursing Homes.Community acquired infections in older patients admitted to hospital from care homes versus the community: cohort study of microbiology and outcomes Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study.Colonization with Multi-Drug Resistant Organisms in Nursing Homes: Scope, Importance, and Management Salmonella and Escherichia coli contamination of poultry meat from a processing plant and retail markets in Ibadan, Oyo State, Nigeria.Genotypic-phenotypic discrepancies between antibiotic resistance characteristics of Escherichia coli isolates from calves in management settings with high and low antibiotic use Risk factors for infection with Escherichia coli in nursing home residents colonized with fluoroquinolone-resistant E. coli.Fluoroquinolone-resistant uncomplicated urinary tract infections, Chinese herbal medicine may provide help.SHEA/APIC guideline: infection prevention and control in the long-term care facility, July 2008.Fluoroquinolone-resistant Escherichia coli carriage in long-term care facility SHEA/APIC Guideline: Infection prevention and control in the long-term care facility.Antibiotic resistance in non-major metropolitan skilled nursing facilities: prevalence and interfacility variation.Do we really know the prevalence of multi-drug resistant Escherichia coli in the territorial and nosocomial population?Patterns of antimicrobial use among nursing home residents with advanced dementia.Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system.Epidemiology of antimicrobial resistance among gram-negative organisms recovered from patients in a multistate network of long-term care facilities.Risk factors for the development of gastrointestinal colonization with fluoroquinolone-resistant Escherichia coli in residents of long-term care facilities.Reducing inappropriate antibiotic prescribing in the residential care setting: current perspectives.An antimicrobial stewardship program with a focus on reducing fluoroquinolone overuse.The role of fluoroquinolones in the management of urinary tract infections in areas with high rates of fluoroquinolone-resistant uropathogens.Epidemiology and characteristics of Escherichia coli sequence type 131 (ST131) from long-term care facility residents colonized intestinally with fluoroquinolone-resistant Escherichia coli.Antimicrobial susceptibility of long term care facility and general practice urine samples in patients 65 years and older: an observational study.Acquisition of multidrug-resistant gram-negative bacteria: incidence and risk factors within a long-term care population.Optimizing antimicrobial use in nursing homes: no longer optional.Longitudinal trends in antibiotic resistance in US nursing homes, 2000-2004.Outbreak of healthcare-associated infection and colonization with multidrug-resistant Salmonella enterica serovar Senftenberg in Florida.Microbiological appraisal of levofloxacin activity against Pseudomonas aeruginosa biofilm in combination with different calcium chanel blockers in vitro.

P2860

Q33835311-EA7B6924-718A-4927-93FD-4292A85F564A Q34097674-D9689DBA-F7B8-42A8-9A8F-B580C42620CF Q34554832-ECA8489F-CF44-4748-B29E-5A2FAA5AD6F6 Q34578707-57129FDB-93F3-4F04-A5B7-94BA733BB1BC Q34680622-E03F094D-02B3-40A6-9C0C-13E2C4E2B1C4 Q35049907-A67E51FC-4C70-47BC-B0E0-A90B1DD694D3 Q35059167-B940BF64-1EC2-449B-9901-3A3EC896C516 Q35077320-9E8FA4E6-9DC9-4727-AB6B-92908491211F Q35478879-A40A3F06-DFA9-4CAC-A85B-318773B5E104 Q35657071-E4B9E64F-81DC-4CCB-ABBF-06C0F51DF35A Q35870420-48745127-9B5C-4A38-952F-C13CDF59D88C Q36009459-3F505CBE-6CDC-4C0A-9590-250E843AF638 Q36031503-4FD52621-1AC8-4388-A46C-440F20DCB17F Q36569193-37D8BFCE-8796-43A7-A1CD-315E250B67F4 Q36813752-E1869928-94AB-4EF9-A1E1-99A3A0C3F272 Q37160979-3112ED2A-E100-427B-B94F-0690078A2A75 Q37383945-581A348F-9CBD-4C6F-91A8-3095CC142C58 Q37402216-987B17B7-C39B-45F0-A637-DF0E7E94ED00 Q37443080-7B315AB3-7D88-4CDA-B7DC-902A16B6B514 Q37490618-BB426F14-D0F5-4E1F-8907-31A21D78D70F Q37498877-06170B45-14FD-42FD-9BE3-ADBFC4F0F91D Q37952621-18D5D1B0-E6CA-4A7A-ACCC-A45ED4125F50 Q38784666-84C6F58D-5440-4A7C-8FF5-19437EF2334F Q38806162-2E8F4863-66F6-4EA6-A868-9DD0D4BE469F Q42869548-E6955D35-BEEC-4260-8719-16B31C616A9B Q43085008-5E47F6D6-938F-458C-A9BA-98037E6A0D24 Q43422109-1C2503C4-4389-47D4-8C08-3CD2FD63BA94 Q43518578-C474F97D-2C9C-4A08-8BDD-E4A959794DAC Q46021297-1661BC12-1AF2-4F50-8BB8-1192AF8E91D2

P2860

Longitudinal trends in antimicrobial susceptibilities across long-term-care facilities: emergence of fluoroquinolone resistance.

http://www.wikidata.org/entity/Q40448254

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Longitudinal trends in antimic ...... of fluoroquinolone resistance.

@en

type

label

Longitudinal trends in antimic ...... of fluoroquinolone resistance.

@en

prefLabel

Longitudinal trends in antimic ...... of fluoroquinolone resistance.

@en

P1433

Q40448254-B338B7C9-9688-44E6-A4AC-4CED708BB4D7

P1476

Q40448254-D4ADF34A-2B42-4CA1-87D2-85A68632C821

P2093

Q40448254-2B51E332-4E24-4F26-86ED-38B4604C64D2

Q40448254-3CE604C4-A240-4E61-B8FC-1DBF4ABB7636

Q40448254-4D524A65-B881-4D5C-81F7-CFE269C2E41F

Q40448254-5C368AA7-B107-48C9-8D57-2E7589D4C411

Q40448254-6DA295A0-0EFC-4167-B055-2E9B31D84801

Q40448254-AEA395E2-760B-47AF-9337-BDBFB7037DBD

P2860

Q40448254-02A7812E-38A2-4106-8A94-12B6103B0D80

Q40448254-10569832-E489-48B5-9A46-C109940DB627

Q40448254-23203351-1584-4B94-9E0F-3034C0C9DD3A

Q40448254-2C85AC7D-9AB5-40BB-973B-76A3941C5B14

Q40448254-45DC6866-8DF4-4CEB-8915-A0EF33BFF964

Q40448254-499B92B7-1FF2-417A-B72F-A1D1D4FE0F6C

Q40448254-58C4C7CB-9E2F-4F0D-B502-EBED0781E21B

Q40448254-5BBCE79B-8F49-472D-A336-1EA2661DE0A8

Q40448254-6514D5BD-D050-4BE4-9BD3-8F33C4F38C8F

Q40448254-6B27A203-95A4-473B-9F39-341FB900E16B

P304

Q40448254-B3F0188C-A079-4B94-8506-D3096D627EF8

P31

Q40448254-F2E82F95-449A-487D-957A-0B33406BDF33

P356

Q40448254-EBF19922-1B71-4EFC-BADD-6F4D5C275803

P433

Q40448254-20296617-69CA-4734-BE50-646A9304834D

P478

Q40448254-EC1A5FF7-E86E-4119-BB48-C8EEEF6CD09A

P50

Q40448254-115E2D5E-9C58-4EB1-8C56-7E805C7BCECD

P577

Q40448254-DC67B398-0ED9-47ED-8DF9-42BB3D5C4165

P5875

Q40448254-FA16500A-3257-4B25-88A1-D47B52BECCE8

P698

Q40448254-24EDD44C-A329-44AB-AF18-5D7CFB7C04A4

P356

P1433

Infection Control and Hospital Epidemiology

P1476

Longitudinal trends in antimic ...... of fluoroquinolone resistance

@en

P2093

Donald D Stieritz

http://www.w3.org/2001/XMLSchema#string

Ebbing Lautenbach

http://www.w3.org/2001/XMLSchema#string

Joel N Maslow

http://www.w3.org/2001/XMLSchema#string

Lesley S Carson

http://www.w3.org/2001/XMLSchema#string

Melissa Viray

http://www.w3.org/2001/XMLSchema#string

Warren B Bilker

http://www.w3.org/2001/XMLSchema#string

P2860

Maintaining fluoroquinolone class efficacy: review of influencing factors.

Antimicrobial resistance patterns in urinary isolates from nursing home residents. Fifteen years of data reviewed.

Effect of duplicate isolates of methicillin-susceptible and methicillin-resistant Staphylococcus aureus on antibiogram data.

New uses for new and old quinolones and the challenge of resistance.

The burden of infection in long-term care.

Antibiotic use in long-term-care facilities: many unanswered questions.

Multiple antibiotic-resistant bacteria in long-term-care facilities: An emerging problem in the practice of infectious diseases.

Preventing infections in non-hospital settings: long-term care.

Co-trimoxazole-sensitive, methicillin-resistant Staphylococcus aureus, Israel, 1988-1997

Trimethoprim-sulfamethoxazole revisited.

P304

56-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/502487

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

Darren R. Linkin

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8040087

http://www.w3.org/2001/XMLSchema#string

P698

15693409

http://www.w3.org/2001/XMLSchema#string